Korean J Otorhinolaryngol-Head Neck Surg.  2020 Nov;63(11):497-504. 10.3342/kjorl-hns.2020.00066.

Comparison among Three Different Steroid Therapies for Idiopathic Sudden Sensorineural Hearing Loss

• Jung DJ
• Lee J
• Yoo MH
• Lee KY

• KMID: 2509260
• DOI: http://doi.org/10.3342/kjorl-hns.2020.00066

Abstract

Background and Objectives
The optimal dose or type of systemic steroid for treating idiopathic sudden sensorineural hearing loss (ISSNHL) is unclear. Herein, we compare the efficacy of three steroid treatment protocols.
Subjects and Method
We reviewed the medical records of 140 adult ISSNHL patients from a tertiary medical center. The patients were divided into three groups based on their treatment regimen: Group 1 received intravenous 10 mg/day dexamethasone combined with intratympanic (IT) steroid injection, followed by prednisolone for 5 days after discharge; Group 2 received 10 mg/day dexamethasone for 5 days, followed by 5 mg/day for 5 days over a 10-day hospitalization period; and Group 3 received 10 mg/day dexamethasone combined with IT steroid injection during a 5-day hospital stay, followed by 5 mg/day dexamethasone for 5 days after discharge. The hearing thresholds were measured using an automatic audiometer at 0.5, 1, 2, 3, 4, and 8 kHz. Hearing recovery on Day 90 was categorized according to Siegel’s criteria.
Results
Univariate and multivariate analyses showed that patients in Group 3 had the lowest hearing thresholds, and the best results for speech reception threshold and speech discrimination scores. The impact of favorable thresholds in Group 3 was better among patients with a baseline average hearing threshold of ＜70 dB. Complete recovery was more likely in Group 3 than in the other groups, based on the odds ratios.
Conclusion
Administration of dexamethasone-based systemic steroid combined with IT steroid injection and a relatively long hospitalization period produced the most favorable result.

Keyword

Dexamethasone; Intratympanic injection; Sudden sensorineural hearing loss